Abstract:Abstract Motivation Anticancer peptides (ACPs) have recently emerged as effective anticancer drugs in cancer therapy. Machine learning-based predictors have been developed to identify ACPs and achieve satisfactory performance. However, existing methods suffer from experience-based feature engineering, which not only restricts the representation ability of the models to a certain extent but also lacks adaptivity for different data, limiting the further improvement of the predictive performance and impacting the robustness of the predictive models. To alleviate the above problems, we propose a novel deep-learning-based predictor named ACPred-LAF, in which we propose a novel multisense and multiscaled embedding algorithm to automatically learn and extract context sequential characteristics of ACPs. Results Through the feature comparative analysis, we demonstrate that our learnable and self-adaptive embedding features are better than hand-crafted features in capturing discriminative information, which can effectively benefit the performance improvement for ACP prediction. In addition, benchmarking comparison results demonstrate that our ACPred-LAF outperforms the state-of-the-art methods both on existing benchmark datasets and our newly constructed dataset. Furthermore, we also prove and validate the robustness of the model via the data interference experiment. To avoid potential evaluation bias, here, we construct a new ACP benchmark dataset named ACP-Mixed by integrating existing datasets. We expect our newly constructed dataset to be a golden standard benchmark dataset in this field. To facilitate the use of our model, we develop a web server as the implementation of ACPred-LAF. Availability and implementation Our proposed ACPred-LAF, newly constructed benchmark dataset ACP-Mixed are open source collaborative initiatives available in the GitHub repository (https://github.com/TearsWaiting/ACPred-LAF). Besides, a webserver as the implementation of ACPred-LAF that can be accessed via: http://server.malab.cn/ACPred-LAF. Supplementary information Supplementary data are available at Bioinformatics online.

Anticancer peptides prediction with deep representation learning features

ACP-DL: A Deep Learning Long Short-Term Memory Model to Predict Anticancer Peptides Using High-Efficiency Feature Representation

DeepACP: A Novel Computational Approach for Accurate Identification of Anticancer Peptides by Deep Learning Algorithm

EnACP: an Ensemble Learning Model for Identification of Anticancer Peptides

ACP-DRL: an anticancer peptides recognition method based on deep representation learning

Inacp: an Integrated Approach to the Prediction of Anticancer Peptides.

Efficient prediction of anticancer peptides through deep learning

iACP-DFSRA: Identification of Anticancer Peptides Based on a Dual-channel Fusion Strategy of ResCNN and Attention

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

ACP-ML: A sequence-based method for anticancer peptide prediction

Learning embedding features based on multisense-scaled attention architecture to improve the predictive performance of anticancer peptides

Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

Deep-Representation-Learning-Based Classification Strategy for Anticancer Peptides

Prediction of Anticancer Peptides Using a Low-Dimensional Feature Model

Anti-Cancer Peptides Identification and Activity Type Classification with Protein Sequence Pre-training

MA‐PEP: A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism

Anti-cancer Peptide Recognition Based on Grouped Sequence and Spatial Dimension Integrated Networks

Contrastive learning for enhancing feature extraction in anticancer peptides

ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction

ACPScanner: Prediction of Anticancer Peptides by Integrated Machine Learning Methodologies